Published in BMJ on February 11, 2006
How does the tobacco industry attempt to influence marketing regulations? A systematic review. PLoS One (2014) 2.75
The tobacco industry in developing countries. BMJ (2006) 1.68
Tobacco industry issues management organizations: creating a global corporate network to undermine public health. Global Health (2008) 1.67
The case for OFSMOKE: how tobacco price regulation is needed to promote the health of markets, government revenue and the public. Tob Control (2010) 1.65
Transnational tobacco company influence on tax policy during privatization of a state monopoly: British American Tobacco and Uzbekistan. Am J Public Health (2006) 1.57
Population causes and consequences of leading chronic diseases: a comparative analysis of prevailing explanations. Milbank Q (2008) 1.57
The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control (2012) 1.53
Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control (2007) 1.49
Corporate Power and Social Policy: The Political Economy of the Transnational Tobacco Companies. Glob Soc Policy (2009) 1.23
Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet (2015) 1.20
The invisible hand: how British American Tobacco precluded competition in Uzbekistan. Tob Control (2007) 1.09
Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials. Tob Control (2012) 1.08
The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR. J Bus Ethics (2013) 1.04
Public attitudes towards smoking and tobacco control policy in Russia. Tob Control (2008) 1.02
British American Tobacco's partnership with Earthwatch Europe and its implications for public health. Glob Public Health (2011) 1.02
Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents. PLoS Med (2012) 1.01
A review of the impacts of tobacco industry privatisation: Implications for policy. Glob Public Health (2011) 0.96
Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control. PLoS Med (2012) 0.95
"A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok. PLoS Med (2008) 0.83
The Policy Dystopia Model: An Interpretive Analysis of Tobacco Industry Political Activity. PLoS Med (2016) 0.81
British American Tobacco's failure in Turkey. Tob Control (2008) 0.78
Tobacco: are we all to blame? BMJ (2006) 0.75
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet (2009) 15.10
Health effects of financial crisis: omens of a Greek tragedy. Lancet (2011) 8.45
Financial crisis, austerity, and health in Europe. Lancet (2013) 8.34
Mass privatisation and the post-communist mortality crisis: a cross-national analysis. Lancet (2009) 5.84
Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet (2007) 5.39
Outcomes of variation in hospital nurse staffing in English hospitals: cross-sectional analysis of survey data and discharge records. Int J Nurs Stud (2006) 5.37
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Post-communist transition and health in Europe. BMJ (2004) 4.90
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Effects of the 2008 recession on health: a first look at European data. Lancet (2011) 4.80
WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet (2008) 4.53
How to achieve international action on falsified and substandard medicines. BMJ (2012) 4.36
Increase in state suicide rates in the USA during economic recession. Lancet (2012) 4.28
Raising the priority of preventing chronic diseases: a political process. Lancet (2010) 4.16
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
Suicides associated with the 2008-10 economic recession in England: time trend analysis. BMJ (2012) 3.87
Looking inside the tobacco industry: revealing insights from the Guildford Depository. Addiction (2004) 3.86
Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet (2010) 3.82
Why the GMC should set up a central registry of doctors' competing interests. BMJ (2014) 3.69
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68
The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ (2005) 3.49
The effect of the late 2000s financial crisis on suicides in Spain: an interrupted time-series analysis. Eur J Public Health (2013) 3.37
Drivers of inequality in Millennium Development Goal progress: a statistical analysis. PLoS Med (2010) 3.30
Migration and health in an increasingly diverse Europe. Lancet (2013) 3.24
Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet (2004) 3.11
Mortality trends and setbacks: global convergence or divergence? Lancet (2004) 3.08
Budget crises, health, and social welfare programmes. BMJ (2010) 3.08
Smoke free hospitals. BMJ (2003) 3.05
Getting children to eat more fruit and vegetables: a systematic review. Prev Med (2005) 3.03
Health service utilization in the former soviet union: evidence from eight countries. Health Serv Res (2004) 3.01
Improving child health services in the UK: insights from Europe and their implications for the NHS reforms. BMJ (2011) 2.98
Measuring the health of nations: analysis of mortality amenable to health care. BMJ (2003) 2.90
Banking crises and mortality during the Great Depression: evidence from US urban populations, 1929-1937. J Epidemiol Community Health (2011) 2.86
The International Monetary Fund and tobacco: a product like any other? Int J Health Serv (2009) 2.77
Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med (2012) 2.71
The evolving pattern of avoidable mortality in Russia. Int J Epidemiol (2003) 2.70
Interventions designed to increase adult fruit and vegetable intake can be effective: a systematic review of the literature. J Nutr (2005) 2.61
Prison health in Russia: the larger picture. J Public Health Policy (2005) 2.57
Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review. Int J Epidemiol (2009) 2.55
Academic output of 9 years of EU investment into health research. Lancet (2012) 2.47
Public health in the new era: improving health through collective action. Lancet (2004) 2.45
Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ (2005) 2.44
Health expectancy in the Russian Federation: a new perspective on the health divide in Europe. Bull World Health Organ (2004) 2.43
Hospital mortality league tables. BMJ (2003) 2.40
What can global health institutions do to help strengthen health systems in low income countries? Health Res Policy Syst (2010) 2.31
Responding to the economic crisis: a primer for public health professionals. J Public Health (Oxf) (2010) 2.25
The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. Eur J Public Health (2012) 2.22
The whole truth and nothing but the truth? The research that Philip Morris did not want you to see. Lancet (2005) 2.12
Tobacco: a product like any other? Health Econ Policy Law (2011) 2.03
Aliphatic alcohol contaminants of illegally produced spirits inhibit phagocytosis by human granulocytes. Immunopharmacol Immunotoxicol (2013) 2.01
Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007. Alcohol Clin Exp Res (2008) 2.01
Is the increasing policy use of Impact Assessment in Europe likely to undermine efforts to achieve healthy public policy? J Epidemiol Community Health (2010) 1.97
British American Tobacco and Formula One motor racing. BMJ (2004) 1.96
"Key to the future": British American tobacco and cigarette smuggling in China. PLoS Med (2006) 1.94
Improving diet and physical activity: 12 lessons from controlling tobacco smoking. BMJ (2005) 1.93
Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy (2008) 1.89
Universal health coverage anchored in the right to health. Bull World Health Organ (2013) 1.88
Health reform in central and eastern Europe and the former Soviet Union. Lancet (2009) 1.87
Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Am J Public Health (2004) 1.87
Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A (2008) 1.86
Potential causes and health effects of rising global food prices. BMJ (2009) 1.84
Relationship of soft drink consumption to global overweight, obesity, and diabetes: a cross-national analysis of 75 countries. Am J Public Health (2013) 1.84
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents. PLoS Med (2011) 1.82
Tobacco industry influence on science and scientists in Germany. Am J Public Health (2005) 1.80
Five metaphors about global-health policy. Lancet (2008) 1.78
The contribution of health to the economy in the European Union. Public Health (2006) 1.77
A comparative analysis of health policy performance in 43 European countries. Eur J Public Health (2013) 1.77
Alcohol and Russian mortality: a continuing crisis. Addiction (2009) 1.75
Ageing in the European Union. Lancet (2013) 1.74
Understanding informal payments for health care: the example of Bulgaria. Health Policy (2002) 1.73
Will austerity cuts dismantle the Spanish healthcare system? BMJ (2013) 1.73
The impact of universal National Health Insurance on population health: the experience of Taiwan. BMC Health Serv Res (2010) 1.71
Cross-national comparisons of human resources for health - what can we learn? Health Econ Policy Law (2006) 1.67
The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One (2011) 1.64
Resilience thinking in health protection. J Public Health (Oxf) (2011) 1.63
Health care capacity and allocations among South Africa's provinces: infrastructure-inequality traps after the end of apartheid. Am J Public Health (2011) 1.61
Health systems and policy research in Europe: Horizon 2020. Lancet (2013) 1.59
Transnational tobacco company influence on tax policy during privatization of a state monopoly: British American Tobacco and Uzbekistan. Am J Public Health (2006) 1.57
Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health (2011) 1.57
Implementing general practice in Russia: getting beyond the first steps. BMJ (2005) 1.56
Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet (2013) 1.55
Health impacts of increasing alcohol prices in the European Union: a dynamic projection. Prev Med (2012) 1.55
Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health. Tob Control (2010) 1.55
Fee-for-service or donation? Hungarian perspectives on informal payment for health care. Soc Sci Med (2005) 1.54
How can quality of health care be safeguarded across the European Union? BMJ (2008) 1.53
Patient mobility in the European Union. BMJ (2007) 1.52
Inequalities in male mortality by occupational class, perceived status and education in Russia, 1994-2006. Eur J Public Health (2011) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Determinants of smoking in eight countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Addiction (2004) 1.51
Denialism: what is it and how should scientists respond? Eur J Public Health (2009) 1.50
Social transition and substance abuse. Addiction (2005) 1.50
Illegally produced alcohol. BMJ (2012) 1.50
Equity and economics of kidney disease in sub-Saharan Africa. Lancet (2013) 1.49
Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control (2007) 1.49
"The law was actually drafted by us but the Government is to be congratulated on its wise actions": British American Tobacco and public policy in Kenya. Tob Control (2007) 1.47
Alcohol consumption and self-reported (SF12) physical and mental health among working-aged men in a typical Russian city: a cross-sectional study. Addiction (2013) 1.47
"Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents. PLoS Med (2010) 1.47